Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease
Top Cited Papers
- 1 January 2000
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 45 (7) , 1462-1464
- https://doi.org/10.1023/a:1005588911207
Abstract
The possible role of Saccharomyces boulardii, a nonpathogenic yeast with beneficial effects on the human intestine, in the maintenance treatment of Crohn’s disease has been evaluated. Thirty-two...Keywords
This publication has 18 references indexed in Scilit:
- Anti- Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's DiseaseAmerican Journal of Gastroenterology, 1998
- Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic roleGut, 1998
- Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.Digestive Diseases and Sciences, 1998
- Controlled trial of oral 5‐aminosalicylic acid for the prevention of early relapse in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1997
- Antibiotics in inflammatory bowel disease: new choices for an old disease.1994
- A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile DiseaseJAMA, 1994
- Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea--a pilot study.1993
- Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's diseaseGastroenterology, 1992
- Prevention of further recurrences ofClostridium difficile colitis withSaccharomyces boulardiiDigestive Diseases and Sciences, 1990
- Response of Human and Rat Small Intestinal Mucosa to Oral Administration of Saccharomyces boulardiiPediatric Research, 1986